Patent details

LUC00198 Product Name: baloxavir marboxil ou un sel pharmaceutiquement acceptable de celui-ci

Basic Information

Publication number:
LUC00198
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP181891938
Legal Status:
Inactive
Application number:
LUC00198
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1500
Marketing Authorization Type:
Marketing Authorization Date:
08/01/2021
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
04/03/2021
First Marketing Authorization date:
08/01/2021
Grant date:
04/10/2024
Activation date:
Publication date:
04/03/2021
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
08/01/2036
SPC Extension Expiration:
08/01/2036
Rejection date:
Withdrawal date:

Owner

From:
04/03/2021
 
 

Name:
SHIONOGI & CO., LTD
Address:
1-8, Doshomachi 3-chome, Chuo-ku Osaka-shi Osaka 541-0045, Japan (JP)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
04/03/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2021/05
Publication date:
13/04/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Section D : Granted supplementary protection certificates – I2 publication
Filing date Document type Number of pages
04/03/2021 Marketing authorization 3
04/03/2021 MA publication 10
04/03/2021 Application Form 3
04/03/2021 Outgoing Correspondence 1
04/03/2021 Summary of the product caracteristics 31
04/03/2021 Publication 1
04/10/2024 Publication 1
04/10/2024 Certificate 1
04/10/2024 Outgoing Correspondence 1